Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Jon C. Ogg | Apr 22, 2014 at 12:00 PM EDT

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off…

Trey Thoelcke | Apr 7, 2014 at 8:25 AM EDT

Credit Suisse Says Grit Your Teeth and Buy Biotech

In a new report, the Credit Suisse team says large cap biotech is cheaper than the S&P 500 on 2016…

Jon C. Ogg | Apr 4, 2014 at 8:20 AM EDT

Stifel Says Strong Earnings Will Reignite Biotech Rally

ThinkstockWhen the biotech sell-off started in late February, the stocks had been market leaders for almost four years. The staggering…

Jon C. Ogg | Apr 2, 2014 at 3:37 PM EDT

Biotech Giants Now Priced Like Old World Drug Stocks

Jon OggMost investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position…

Jon C. Ogg | Apr 2, 2014 at 8:20 AM EDT

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…

Trey Thoelcke | Mar 31, 2014 at 12:50 PM EDT

Teva’s Latest Victory in Effort to Protect Key Patents

Teva Pharmaceutical shares reached a new multiyear high Monday after the U.S. Supreme Court agreed to hear its appeal to…

Jon C. Ogg | Mar 27, 2014 at 8:55 AM EDT

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley…

Jon C. Ogg | Mar 27, 2014 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, March 27, 2014.…

Trey Thoelcke | Mar 24, 2014 at 9:55 AM EDT

Top Biotechnology Stocks On Sale Again

For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…

Trey Thoelcke | Mar 11, 2014 at 8:45 AM EDT

Catalysts That Could Push Top Biotech Stocks Even Higher

Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In…

Jon C. Ogg | Mar 6, 2014 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Biogen, Exxon, MarkWest, Yum! and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms in Thursday, March 6, 2014.…

Trey Thoelcke | Mar 4, 2014 at 8:50 AM EST

Merrill Lynch’s Top Health Care Stocks to Buy Now

Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…

Trey Thoelcke | Feb 27, 2014 at 7:00 AM EST

Short Sellers Return to Biotech Stocks

After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical…

Trey Thoelcke | Feb 17, 2014 at 9:40 AM EST

Biogen Idec Chairman: New Boss Same as the Old Boss?

Biogen Idec has announced that Chairman William D. Young will retire from the its board of directors and will be…

Jon C. Ogg | Jan 31, 2014 at 8:20 AM EST

Jefferies Says Buy Any Pullback on Top Focus Stocks for Big Gains

The equity team at Jefferies has pulled their best ideas for clients to review while the market is mired in…

1 … 27 28 29 30 31 … 41

Biogen : BIIB

All Biogen Articles

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

Credit Suisse Says Grit Your Teeth and Buy Biotech

Stifel Says Strong Earnings Will Reignite Biotech Rally

Biotech Giants Now Priced Like Old World Drug Stocks

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Teva’s Latest Victory in Effort to Protect Key Patents

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

Top Biotechnology Stocks On Sale Again

Catalysts That Could Push Top Biotech Stocks Even Higher

Top Analyst Upgrades and Downgrades: Biogen, Exxon, MarkWest, Yum! and More

Merrill Lynch’s Top Health Care Stocks to Buy Now

Short Sellers Return to Biotech Stocks

Biogen Idec Chairman: New Boss Same as the Old Boss?

Jefferies Says Buy Any Pullback on Top Focus Stocks for Big Gains

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Biogen : BIIB

All Biogen Articles

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

Credit Suisse Says Grit Your Teeth and Buy Biotech

Stifel Says Strong Earnings Will Reignite Biotech Rally

Biotech Giants Now Priced Like Old World Drug Stocks

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Teva’s Latest Victory in Effort to Protect Key Patents

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

Top Biotechnology Stocks On Sale Again

Catalysts That Could Push Top Biotech Stocks Even Higher

Top Analyst Upgrades and Downgrades: Biogen, Exxon, MarkWest, Yum! and More

Merrill Lynch’s Top Health Care Stocks to Buy Now

Short Sellers Return to Biotech Stocks

Biogen Idec Chairman: New Boss Same as the Old Boss?

Jefferies Says Buy Any Pullback on Top Focus Stocks for Big Gains

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%